JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

Search results for: 'cpp1 7 npy19 23 ala31 aib32 gln34 hpancreatic polypeptide'

A8328 LDK378

Target: ALK

Summary: Potent ALK inhibitor

insoluble in H2O; ≥13.95 mg/mL
B2287 LY364947

1 Citation

Summary: inhibitor of TGF-β type I receptor kinase domain

insoluble in EtOH; insoluble in H2O; ≥24.4 mg/mL
A8366 ARRY-380

Target: HER2

Summary: Tyrosine kinase HER2 and p95-HER2 inhibitor

≥28.5 mg/mL
B2191 Dequalinium Chloride

Target: PKC|Calcium-Activated Potassium (KCa) Channels

Summary: anti-tumor agent and PKC inhibitor

insoluble in H2O; insoluble in ETOH; insoluble in DMSO
A8721 CBR-5884

1 Citation

Target: 3-phosphoglycerate dehydrogenase

Summary: selective inhibitor of PHGDH

insoluble in EtOH; insoluble in H2O; ≥16.8 mg/mL
A1832 Doxorubicin (Adriamycin) HCl

2 Citation

Target: Topoisomerases

Summary: Antitumour antibiotic,inhibits TOPO II.

≥29 mg/mL
A4496 NSC 3852

Target: Histone Deacetylases (HDACs)

Summary: HDAC inhibitor

insoluble in EtOH; insoluble in H2O; ≥7.35 mg/mL
A8882 THZ1

12 Citation

Target: Cyclin-Dependent Kinases

Summary: Covalent CDK7 inhibitor,potent and selective

≥28.3 mg/mL
A8476 MK-2461

Target: FLT3|PDGFR|MET|Ron

Summary: C-Met (WT/mutants) inhibitor

≥24.8 mg/mL
A5057 MGCD-265

Target: VEGFR|c-MET

Summary: Met/Flt/Flk/Ron/Tie-2 inhibitor

≥25.9 mg/mL